Literature DB >> 21575322

Complicated features in a young child with influenza B virus pneumonia and co-infection with Stenotrophomonas maltophilia.

S-H Chen1, I-A Huang, C-T Wu, S-H Hsia, P-C Hung, C-H Chiu.   

Abstract

A 3.5-year-old child with influenza B virus pneumonia developed pneumomediastinum and subcutaneous emphysema on the 3rd day of illness. Bronchoscopy demonstrated obstruction of the left main bronchus by mucopurulent sputum. Culture of the broncho-alveolar lavage yielded Stenotrophomonas maltophilia. After the respiratory complications resolved (11 days), the patient developed neurological symptoms and was diagnosed as acute disseminated encephalomyelitis (ADEM). Stenotrophomonas maltophilia was probably a factor in the development of pneumomediastinum. To our knowledge, this is the first case report of influenza virus infection with Stenotrophomonas maltophilia co-infection associated with spontaneous pneumomediastinum.

Entities:  

Mesh:

Year:  2011        PMID: 21575322     DOI: 10.1179/1465328111Y.0000000012

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  3 in total

Review 1.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

2.  Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.

Authors:  Andrew J Burnham; Jianling Armstrong; Anice C Lowen; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

3.  A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a "spontaneous" complication?

Authors:  Anna Cancelliere; Giada Procopio; Maria Mazzitelli; Elena Lio; Maria Petullà; Francesca Serapide; Maria Chiara Pelle; Chiara Davoli; Enrico Maria Trecarichi; Carlo Torti
Journal:  Clin Case Rep       Date:  2021-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.